Karnon, Jonathan; Delea, Thomas; Johnston, Stephen R.D.; … - In: PharmacoEconomics 24 (2006) 3, pp. 237-250
Background: MA17 was a randomised placebo-controlled trial of letrozole 2.5 mg/day in 5187 estrogen receptor … the lifetime cost effectiveness of letrozole in this setting. Methods: A Markov model was used to estimate the incremental … cost per QALY gained with extended adjuvant letrozole versus no therapy. Probabilities of disease progression and death …